{"id":2966,"date":"2011-01-28T11:08:02","date_gmt":"2011-01-28T16:08:02","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=2966"},"modified":"2011-01-28T11:08:02","modified_gmt":"2011-01-28T16:08:02","slug":"endo-pharma-orion-corp-to-advance-cancer-drugs","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=2966","title":{"rendered":"Endo Pharma, Orion Corp. to Advance Cancer Drugs"},"content":{"rendered":"<figure id=\"attachment_1748\" aria-describedby=\"caption-attachment-1748\" style=\"width: 300px\" class=\"wp-caption alignright\"><a href=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/LabGlass_USTRgov.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1748\" title=\"LabGlass_USTRgov\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/LabGlass_USTRgov.jpg\" alt=\"Beakers and molecule model (USTR.gov)\" width=\"300\" height=\"199\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/LabGlass_USTRgov.jpg 300w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/LabGlass_USTRgov-150x99.jpg 150w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><figcaption id=\"caption-attachment-1748\" class=\"wp-caption-text\">(USTR.gov)<\/figcaption><\/figure>\n<p><a href=\"http:\/\/phx.corporate-ir.net\/phoenix.zhtml?c=231492&amp;p=irol-newsArticle&amp;ID=1521192&amp;highlight=\">Endo Pharmaceuticals<\/a> in Chadds Ford, Pennsylvania and <a href=\"http:\/\/www.orion.fi\/en\/\">Orion Corporation<\/a> in Espoo, Finland said today they have a collaboration agreement for drug research and development in oncology.<\/p>\n<p>The partnership aims to advance eight discovery-phase cancer drug candidates by combining their relevant R&amp;D programs. The collaboration also gives each company exclusive licensing rights to the other&#8217;s development-ready programs at agreed-upon stages and to share all development costs.<\/p>\n<p>Endo Pharmaceuticals, a specialty health care company, offers a variety of generic and branded drug products. Orion Corp. provides medicinal treatments and diagnostic tests, including drugs for central nervous system, cancer, and pulmonary conditions.<\/p>\n<p>Read more: <a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=2716\">Spirogen, Genentech Partner on Anti-Cancer Therapies<\/a><\/p>\n<p style=\"text-align: center;\">*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Endo Pharmaceuticals in Chadds Ford, Pennsylvania and Orion Corporation in Espoo, Finland said today they have a collaboration agreement for drug research and development in oncology. The partnership aims to advance eight discovery-phase cancer drug candidates by combining their relevant R&amp;D programs. The collaboration also gives each company exclusive licensing rights to the other&#8217;s development-ready [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,16],"tags":[31,21,51,45,84,27],"class_list":["post-2966","post","type-post","status-publish","format-standard","hentry","category-i-p","category-ventures","tag-biomedical","tag-biotech","tag-cancer","tag-europe","tag-licensing","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/2966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2966"}],"version-history":[{"count":3,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/2966\/revisions"}],"predecessor-version":[{"id":2969,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/2966\/revisions\/2969"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}